What is H1N1 influenza. How does the H1N1 vaccine work. What are the types of H1N1 vaccines available. Who should get vaccinated against H1N1. What are the symptoms of H1N1 flu. How can you prevent H1N1 infection. What are the treatment options for H1N1 influenza.

Understanding H1N1 Influenza: The Swine Flu Pandemic

H1N1 influenza, also known as swine flu, emerged as a new strain of influenza virus in 2009, causing a global pandemic. This highly contagious virus spread rapidly across the United States and many other countries, prompting worldwide concern and urgent public health measures.

How does H1N1 spread? The transmission of H1N1 is similar to that of seasonal flu. The virus primarily spreads from person to person through respiratory droplets released when an infected individual coughs or sneezes. Additionally, people can contract the virus by touching contaminated surfaces and then touching their eyes, nose, or mouth.

Recognizing H1N1 Symptoms

The symptoms of H1N1 influenza closely resemble those of seasonal flu. Common signs include:

• Fever
• Cough
• Sore throat
• Sneezing
• Body aches
• Headaches
• Chills
• Fatigue

Some individuals may also experience diarrhea and vomiting. Is H1N1 more severe than seasonal flu? While H1N1 can cause serious complications in some cases, its severity is generally comparable to seasonal influenza. However, certain groups, such as young children, pregnant women, and individuals with underlying health conditions, may be at higher risk for severe illness.

H1N1 Vaccination: The First Line of Defense

Vaccination remains the most effective method to protect against H1N1 influenza. The H1N1 vaccine, developed in response to the 2009 pandemic, is now incorporated into seasonal flu vaccines. These vaccines are produced using the same methods and by the same manufacturers as traditional seasonal flu vaccines, ensuring their safety and efficacy.

Types of H1N1 Vaccines

Two primary forms of H1N1 vaccines are available:

1. Inactivated Influenza Shot: This vaccine contains killed virus and is administered via injection into the muscle. It’s available in two formulations:
   • With thimerosal preservative
   • Preservative-free
2. Live Attenuated Intranasal Vaccine (LAIV): This nasal spray vaccine contains weakened live virus.

Which vaccine is right for you? The choice between the shot and nasal spray depends on various factors, including age, health status, and personal preferences. Consult with your healthcare provider to determine the most suitable option for your situation.

Who Should Get the H1N1 Vaccine?

The Centers for Disease Control and Prevention (CDC) recommends annual flu vaccination for everyone 6 months and older, with rare exceptions. This recommendation includes protection against H1N1 strains. However, certain groups should prioritize vaccination due to their increased risk of complications:

• Pregnant women
• Young children (6 months to 5 years old)
• Adults 65 years and older
• Individuals with chronic health conditions (e.g., asthma, diabetes, heart disease)
• Healthcare workers and caregivers

Can everyone receive the nasal spray vaccine? No, some groups should avoid the nasal spray and opt for the injectable vaccine instead. These include pregnant women, people with certain long-term illnesses, children under 2 years old, and adults 50 years or older.

Preventing H1N1 Infection: Beyond Vaccination

While vaccination is crucial, additional preventive measures can significantly reduce the risk of H1N1 infection. The CDC and World Health Organization (WHO) recommend the following practices:

• Practice proper cough etiquette: Cough into your sleeve or cover your nose and mouth with a tissue when coughing or sneezing. Dispose of used tissues immediately.
• Maintain hand hygiene: Wash your hands frequently with soap and water, especially after coughing or sneezing. Alcohol-based hand sanitizers are also effective.
• Avoid touching your face: Refrain from touching your eyes, nose, or mouth to prevent the spread of germs.
• Maintain social distance: Stay at least 3-6 feet away from sick individuals.
• Stay home when ill: If you suspect you have the flu, remain at home to prevent spreading the virus to others.

How effective are these preventive measures? When combined with vaccination, these practices can significantly reduce the spread of H1N1 and other influenza viruses, helping to protect both individuals and communities.

Treatment Options for H1N1 Influenza

If you contract H1N1 influenza, several treatment options are available to manage symptoms and reduce the risk of complications. The approach to treatment may vary depending on the severity of the illness and individual risk factors.

Antiviral Medications

Antiviral drugs play a crucial role in treating H1N1 influenza. These medications can help reduce the severity and duration of symptoms, as well as prevent serious complications. The most commonly prescribed antivirals for H1N1 include:

• Oseltamivir (Tamiflu)
• Zanamivir (Relenza)
• Peramivir (Rapivab)
• Baloxavir marboxil (Xofluza)

When should antiviral treatment begin? For maximum effectiveness, antiviral treatment should ideally start within 48 hours of symptom onset. However, these medications may still provide benefits if started later, especially for individuals at high risk of complications.

Supportive Care

In addition to antiviral medications, supportive care is essential for managing H1N1 symptoms and promoting recovery. Key elements of supportive care include:

• Rest: Adequate rest allows the body to focus energy on fighting the virus.
• Hydration: Drinking plenty of fluids helps prevent dehydration and loosens mucus.
• Over-the-counter pain relievers: Acetaminophen or ibuprofen can help reduce fever and alleviate body aches.
• Humidifiers: Using a humidifier can help ease congestion and coughing.

Are antibiotics effective against H1N1? Antibiotics are not effective against viral infections like H1N1 influenza. However, they may be prescribed if a secondary bacterial infection develops as a complication of the flu.

H1N1 in Special Populations: Considerations and Precautions

Certain groups require special attention when it comes to H1N1 prevention and treatment. These populations may be at higher risk for complications or may require modified approaches to care.

Pregnant Women

Pregnant women are at increased risk of severe complications from H1N1 influenza. Key considerations for this group include:

• Prioritized vaccination with the inactivated influenza shot
• Early antiviral treatment if infection occurs
• Close monitoring for complications

Can pregnant women safely receive the H1N1 vaccine? Yes, the inactivated influenza vaccine is considered safe and recommended for pregnant women at all stages of pregnancy.

Young Children

Children, especially those under 5 years old, are at higher risk for H1N1-related complications. Special considerations for this age group include:

• Age-appropriate vaccination (children under 6 months cannot be vaccinated)
• Careful monitoring of symptoms and potential complications
• Prompt antiviral treatment if infection is suspected

How does H1N1 affect children differently from adults? Children may experience more severe gastrointestinal symptoms, such as nausea, vomiting, and diarrhea, compared to adults with H1N1.

Individuals with Chronic Health Conditions

People with underlying health conditions, such as asthma, diabetes, or heart disease, face an increased risk of severe H1N1 complications. For these individuals:

• Annual vaccination is crucial
• Early consultation with healthcare providers if flu-like symptoms develop
• Careful management of underlying conditions during illness

What additional precautions should individuals with chronic conditions take? Maintaining regular medication schedules, closely monitoring symptoms, and having an action plan in case of illness are essential steps for those with chronic health conditions.

The Global Impact of H1N1: Lessons Learned and Future Preparedness

The 2009 H1N1 pandemic highlighted the importance of global cooperation and preparedness in responding to emerging infectious diseases. This experience has led to significant advancements in several areas:

Improved Surveillance Systems

The H1N1 pandemic spurred the development and enhancement of global surveillance systems for detecting and monitoring influenza outbreaks. These improvements include:

• Better data sharing between countries
• Enhanced laboratory capabilities for virus identification
• Increased use of technology for real-time outbreak tracking

How have these improvements affected our ability to respond to future pandemics? Enhanced surveillance allows for earlier detection of novel influenza strains, potentially enabling faster response times and more effective containment strategies.

Vaccine Development and Distribution

The H1N1 pandemic accelerated research into vaccine development and production methods. Key advancements include:

• Faster vaccine production techniques
• Improved global vaccine distribution networks
• Enhanced capacity for rapid scale-up of vaccine manufacturing

Have these advancements been applied to other diseases? Yes, the lessons learned from H1N1 vaccine development have contributed to improvements in vaccine technology for other infectious diseases, including the rapid development of COVID-19 vaccines.

Public Health Communication

The pandemic underscored the importance of clear, consistent public health messaging. Improvements in this area include:

• More effective use of social media for health communication
• Enhanced strategies for combating misinformation
• Improved coordination between global health organizations

How has public health communication evolved since the H1N1 pandemic? There’s now a greater emphasis on transparent, timely, and accessible health information, with increased efforts to reach diverse populations through various communication channels.

Ongoing Research and Future Directions in H1N1 Prevention and Treatment

The field of influenza research continues to evolve, with ongoing efforts to improve our understanding of H1N1 and develop more effective prevention and treatment strategies. Some key areas of current research include:

Universal Influenza Vaccines

Scientists are working towards developing a universal influenza vaccine that could provide broad protection against multiple strains, including H1N1. This research focuses on targeting conserved parts of the influenza virus that don’t change significantly from strain to strain.

What are the potential benefits of a universal flu vaccine? A successful universal vaccine could eliminate the need for annual flu shots and provide better protection against pandemic strains.

Novel Antiviral Therapies

Researchers are exploring new antiviral treatments that could be more effective against H1N1 and other influenza strains. Areas of investigation include:

• Drugs that target different stages of the viral life cycle
• Combination therapies to enhance effectiveness and reduce resistance
• Host-directed therapies that boost the body’s immune response

How might these new therapies improve H1N1 treatment? Novel antivirals could potentially offer faster symptom relief, reduce the risk of complications, and be effective even when started later in the course of illness.

Improved Diagnostic Tools

Efforts are underway to develop faster, more accurate diagnostic tests for H1N1 and other influenza strains. These advancements aim to:

• Enable rapid point-of-care testing
• Improve differentiation between influenza strains
• Enhance surveillance capabilities

Why are better diagnostic tools important? Faster, more accurate diagnoses can lead to earlier treatment initiation, better patient outcomes, and more effective public health responses to outbreaks.

h2N1 Influenza (Swine Flu) – APIC

October 18-24, 2009 is International Infection Prevention Week (IIPW). IIPW is an annual event to raise awareness about the importance of infection prevention and what consumers can do to guard against infections.  As h2N1 influenza continues to spread and more people become infected with the virus, APIC’s message for IIPW 2009 focuses on how consumers can stay healthy during this flu season.

Background on h2N1
The 2009 h2N1 influenza virus (previously called swine flu) is a new strain of influenza virus. It is very contagious and has spread to many areas of the United States and other countries resulting in a pandemic.

It is believed that the h2N1 flu spreads the same way that seasonal flu does. These viruses are transmitted mainly from person-to-person as a result of exposure to people who have flu like symptoms who are coughing and/or sneezing. People can also become infected by touching something that has flu virus on it and then touching their eyes, nose or mouth.

Symptoms of h2N1 flu are similar to regular seasonal flu and include: fever, cough, sore throat, sneezing, body aches, headaches, chills and fatigue. Some persons have also reported diarrhea and vomiting.

2009 h2N1 Influenza Vaccine 
Getting vaccinated is the single best way to protect against influenza illness. h2N1 flu vaccines are now available. They are made the same way and by the same manufacturers as seasonal flu vaccine. This vaccine will not prevent influenza-like illnesses caused by other viruses; therefore, you must get both the seasonal influenza vaccine and the h2N1 influenza vaccine. To find out where to get seasonal or h2N1 vaccines, visit http://www.flu.gov/.

There are two kinds of 2009 h2N1 vaccines available:

• 2009 h2N1 flu shot (inactivated influenza shot) – This is just like the annual flu shot that is given with a needle; it has killed virus in it and is injected into the muscle. One form of the vaccine contains a preservative called thimerosal; another form is preservative free. For more information, visit the CDC’s website:  http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-inact-h2n1.pdf
• 2009 h2N1 nasal spray flu vaccine (Live Attenuated Intranasal Vaccine — LAIV). This is a weakened virus in a vaccine that is sprayed into the nose. Certain groups may not get the nasal spray vaccine: pregnant women, people with certain long-term illnesses such as diabetes, asthma etc., children from 6 months to 2 years old, and adults 50 years or older. If you cannot get the nasal spray flu vaccine, you should get the h2N1 flu shot. For more information, please see:  http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-laiv-h2n1.pdf and  http://www.cdc.gov/h2n1flu/vaccination/nasalspray_qa.htm  

The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have identified ways to stay healthy and guard against the flu:

• Cough into your sleeve or cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it.
• Wash your hands often with soap and water, especially after you cough or sneeze. Alcohol-based hand cleaners are also effective and should be used frequently.
• Avoid touching your eyes, nose, or mouth. Germs spread that way.
• Avoid close contact with sick people (stay 3-6 feet away).
• If you get sick, stay home from work or school and limit contact with others to keep from infecting them.

APIC reminds everyone: Do not visit patients in the hospital or any other healthcare facility if you think you may have the flu.

Resources:
www.cdc.gov/h2n1flu
http://www.who.int/csr/disease/swineflu/en/index.html

h2N1 Influenza (Swine Flu) Treatment & Management: Medical Care, Prevention

1. Ma W. Swine influenza virus: Current status and challenge. Virus Res. 2020 Oct 15. 288:198118. [QxMD MEDLINE Link].

2. webmd.com”>Chauhan RP, Gordon ML. A Systematic Review Analyzing the Prevalence and Circulation of Influenza Viruses in Swine Population Worldwide. Pathogens. 2020 May 8. 9 (5):[QxMD MEDLINE Link].

3. CDC. Interim Guidance for Clinicians on the Prevention and Treatment of Swine-Origin Influenza Virus Infection in Young Children. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/childrentreatment.htm. Accessed: April 30, 2009.

4. CDC. Interim Guidance on Specimen Collection and Processing for Patients with Suspected Swine Influenza A (h2N1) Virus Infection. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/specimencollection.htm. Accessed: April 28, 2009.

5. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006 Jan. 12(1):15-22. [QxMD MEDLINE Link].

6. Bresee J. CDC Podcasts: Swine Flu. Centers for Disease Control and Prevention. Available at http://www2c.cdc.gov/podcasts/player.asp?f=11226. Accessed: April 28, 2009.

7. Roan S. Swine flu ‘debacle’ of 1976 is recalled. LA Times. April 27, 2009. Available at http://articles.latimes.com/2009/apr/27/science/sci-swine-history27.

8. CDC. Swine Flu – Vaccine Safety and Emergency Preparedness. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/vaccinesafety/emergency/swineflu.htm. Accessed: April 29, 2009.

9. Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine. 2009 Mar 26. 27(15):2114-20. [QxMD MEDLINE Link].

10. Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/h2N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis. 2008 Jul 15. 198(2):226-33. [QxMD MEDLINE Link].

11. World Health Organization. Influenza-like illness in the United States and Mexico. WHO Epidemic and Pandemic Alert and Response. Available at http://www.who.int/csr/don/2009_04_24/en/index.html. Accessed: April 27, 2009.

12. WHO. Influenza A (h2N1): Special Insights. World Health Organization. Available at http://www.who.int/en/. Accessed: September 1, 2009.

13. McNeil DG Jr. U.S. Declares Public Health Emergency Over Swine Flu. New York Times. April 27, 2009. Available at http://www.nytimes.com/2009/04/27/world/27flu.html?th&emc=th.

14. Swine influenza A (h2N1) infection in two children–Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009 Apr 24. 58(15):400-2. [QxMD MEDLINE Link]. [Full Text].

15. U.S. Department of Health and Human Services. Determination That a Public Health Emergency Exists. Available at http://www.hhs.gov/secretary/phe_swh2n1.html. Accessed: April 27, 2009.

16. CDC. Swine Influenza (Flu). Centers for Disease Control and Prevention. Available at http://www.cdc.gov/h2n1flu/. Accessed: September 1, 2009.

17. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (h2N1) virus in humans. N Engl J Med. 2009 Jun 18. 360(25):2605-15. [QxMD MEDLINE Link].

18. Centers for Disease Control and Prevention (CDC). Update: novel influenza A (h2N1) virus infections – worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep. 2009 May 8. 58(17):453-8. [QxMD MEDLINE Link].

19. CDC. CDC Estimates of 2009 h2N1 Influenza Cases, Hospitalizations and Deaths in the United States, April – October 17, 2009. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/h2n1flu/estimates_2009_h2n1.htm.

20. Obama Declares Swine Flu A National Emergency. The New York Times. October 24, 2009. Available at http://www.nytimes.com/reuters/2009/10/24/world/international-uk-flu-usa-obama.html.

21. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(h2N1) in Mexico. JAMA. 2009 Nov 4. 302(17):1880-7. [QxMD MEDLINE Link].

22. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (h2N1) virus infection. N Engl J Med. 2010 May 6. 362(18):1708-19. [QxMD MEDLINE Link]. [Full Text].

23. Update: Influenza A (h4N2)v Transmission and Guidelines – Five States, 2011. MMWR Morb Mortal Wkly Rep. 2012 Jan 6. 60:1741-4. [QxMD MEDLINE Link].

24. Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (h2N1), 2008-2009 (h2N1), and 2007-2008 (h4N2) infections. JAMA. 2010 Sep 8. 304(10):1091-8. [QxMD MEDLINE Link].

25. Jain S, Benoit SR, Skarbinski J, Bramley AM, Finelli L. Influenza-Associated Pneumonia Among Hospitalized Patients With 2009 Pandemic Influenza A (h2N1) Virus–United States, 2009. Clin Infect Dis. 2012 May. 54(9):1221-1229. [QxMD MEDLINE Link].

26. Myles PR, Semple MG, Lim WS, Openshaw PJ, Gadd EM, Read RC, et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/h2N1 pandemic 2009-2010 in the UK. Thorax. 2012 Mar 14. [QxMD MEDLINE Link].

27. Khandaker G, Zurynski Y, Buttery J, Marshall H, Richmond PC, Dale RC, et al. Neurologic complications of influenza A(h2N1)pdm09: Surveillance in 6 pediatric hospitals. Neurology. 2012 Oct 2. 79(14):1474-1481. [QxMD MEDLINE Link].

28. CDC. Guidance for Clinicians & Public Health Professionals. Centers for Disease Control and Prevention. Available at http://www. cdc.gov/swineflu/guidance/. Accessed: April 27, 2009.

29. National Center for Biotechnology Information. Influenza Virus Resource. Available at http://www.ncbi.nlm.nih.gov/genomes/FLU/SwineFlu.html. Accessed: May 4, 2009.

30. NIAID. NIAID and 2009 h2N1 influenza. National Institute of Allergy and Infectious Diseases. Available at http://www.niaid.nih.gov/topics/flu/h2n1/research/Pages/researchProgram.aspx. Accessed: May 4, 2009.

31. CDC 2009 h2N1 vaccination campaign planning checklist. August 31, 2009. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/h2N1flu/vaccination/statelocal/planning_checklist.htm. Accessed: September 1, 2009.

32. CDC. Novel h2N1 vaccination recommendations. Centers for Disease Control and Prevention. Available at http://www. cdc.gov/h2n1flu/vaccination/acip.htm. Accessed: September 1, 2009.

33. Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (h2N1) — United States, April 2009–August 2010. MMWR Morb Mortal Wkly Rep. 2011 Sep 9. 60:1193-6. [QxMD MEDLINE Link]. [Full Text].

34. Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al. Vaccination against pandemic A/h2N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ. 2012 May 2. 344:e2794. [QxMD MEDLINE Link]. [Full Text].

35. CDC. Interim Guidance for Infection Control for Care of Patients with Confirmed or Suspected Swine Influenza A (h2N1) Virus Infection in a Healthcare Setting. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/guidelines_infection_control. htm. Accessed: April 29, 2009.

36. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. A novel influenza A (h2N1) vaccine in various age groups. N Engl J Med. 2009 Dec 17. 361(25):2414-23. [QxMD MEDLINE Link].

37. US Food and Drug Administration. Letter from the Commissioner to Nation’s Health Care Professionals on h2N1 Vaccine Safety. Available at http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm197733.htm. Accessed: January 14, 2010.

38. [Guideline] Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis. 2019 Mar 5. 68 (6):e1-e47. [QxMD MEDLINE Link].

39. webmd.com”>WHO guidelines for pharmacological management of pandemic (h2N1) 2009 influenza and other influenza viruses. World Health Organization. Available at http://www.who.int/csr/resources/publications/swineflu/h2n1_use_antivirals_20090820/en/index.html. Accessed: August 20, 2009.

40. Graitcer SB, Gubareva L, Kamimoto L, et al. Characteristics of Patients with Oseltamivir-Resistant Pandemic (h2N1) 2009, United States. Emerg Infect Dis. 2011 Feb. 17(2):255-257. [QxMD MEDLINE Link].

41. Hernandez JE, Adiga R, Armstrong R, et al. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (h2N1) under an Emergency IND program in the United States. Clin Infect Dis. 2011 Mar. 52(6):695-706. [QxMD MEDLINE Link]. [Full Text].

42. CDC. Interim Guidance on Antiviral Recommendations for Patients with Confirmed or Suspected Swine Influenza A (h2N1) Virus Infection and Close Contacts. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/recommendations.htm. Accessed: April 28, 2009.

43. CDC. Update: drug susceptibility of swine-origin influenza A (h2N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009 May 1. 58(16):433-5. [QxMD MEDLINE Link]. [Full Text].

44. Oseltamivir-resistant 2009 pandemic influenza A (h2N1) virus infection in two summer campers receiving prophylaxis–North Carolina, 2009. MMWR Morb Mortal Wkly Rep. 2009 Sep 11. 58(35):969-72. [QxMD MEDLINE Link].

45. Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, et al. Oseltamivir ring prophylaxis for containment of 2009 h2N1 influenza outbreaks. N Engl J Med. 2010 Jun 10. 362(23):2166-74. [QxMD MEDLINE Link].

46. CDC. Interim Guidance – Pregnant women and swine influenza: considerations for clinicians. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/swineflu/clinician_pregnant.htm. Accessed: April 29, 2009.

47. Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R. Immunogenicity and safety of pandemic influenza A (h2N1) 2009 vaccine: systematic review and meta-analysis. Influenza Other Respi Viruses. 2011 Mar 21. [QxMD MEDLINE Link].

h2N1 swine flu shot in Moscow

h2N1 swine flu shot in Moscow

Site search

Cancel

Preambula Bot

Preambula Bot

Online

List of dialogues

Available dialogues

You can communicate with doctors and ask any questions to the bot

Log in
in PreAmbula

No questions asked

the administrator is in touch, who
knows your medical history

Log in
in PreAmbula

Personal
widget

with appointments, conclusions
and appointments

Log in
in PreAmbula

1

Hello! I want to sign up

Continue
in the telegram bot

it’s convenient: we are always online
in your phone

Continue

Preambula Bot

To see dialogues with doctors, you need to log in

Hello. If you need to contact a doctor, sign up for an online consultation:

Conditions for the consultation

Sign up for a consultation

5

Share

The world periodically faces waves of seasonal h2N1 type A influenza, the virus of which mutates slightly every year. However, the general human immunity against this disease has always helped people cope with it.

This time, apparently, the virus was subjected to a stronger mutation. Scientists suggest that the disease appeared in Mexico, in the body of pigs. Genetic material from animals, not familiar to the human body, was mixed with the usual set of h2N1 genes.

This modified version of the seasonal flu that is familiar to us was called “swine flu”, and for obvious reasons, aroused the close attention of scientists. As established, the virus continues to mutate, and can be transmitted from person to person.

This circumstance increases the risk of the disease and makes it extremely difficult to create a vaccine against it. The disease, like the common flu, begins with fever, cough, sore throat and muscles, chills and general weakness. Patients often have diarrhea, which is one of the characteristic signs of swine flu.

The only right decision in this case is to call a doctor at home. Self-medication with traditional methods can be fraught with complications and even death. The doctor will make the correct diagnosis and prescribe the necessary treatment. There is currently no specific treatment for swine flu. It is treated in the same way as traditional virus strains. Prevention of the disease is traditional. It is necessary to observe the rules of general hygiene, which is the most important, to minimize visits to crowded places, avoid contact with people who sneeze and cough.

As you know, influenza is transmitted by airborne droplets. For this reason, if you happen to care for the sick, do not forget to wear a gauze bandage. However, we should not forget that it does not guarantee complete protection. The longer the mask is worn, the lower its effectiveness.

And if she began to get wet from breathing, or does not fit snugly to her face, then she is generally useless. There is currently no vaccine for swine flu. Vaccinations, flu shots, against various strains of regular seasonal flu are ineffective, and their use is useless.

Vaccination of the population

• Home
• Citizens
• Vaccination

Anyone can get the flu, but some groups of people are at a higher risk of developing a serious illness. WHO recommends vaccination:

• elderly,
• small children,
• pregnant women,
• people with certain health problems.

These groups are most at risk of developing severe complications from influenza. They should also be vaccinated0103 healthcare workers – both for their own protection and to reduce the risk of infection of patients vulnerable to the virus.

Why get vaccinated

This is the best tool we have at our disposal to prevent influenza and reduce the risk of serious complications and even death.

The effectiveness of the vaccine in different years may vary – it depends on the types of circulating virus and their compliance with the components of the vaccine. In addition, the effectiveness depends on the health and age of the person being vaccinated, as well as on the time that has elapsed since vaccination.

On average, the vaccine prevents about 60% of infections in healthy adults aged 18–64 years. The vaccine becomes effective in about 14 days.

How long does the vaccine last?

The entire epidemiological season.

Can a vaccine cause the flu?

The injection cannot cause the flu because it does not contain a live virus.

Is this vaccine generally safe?

The seasonal flu vaccine has been used for over 50 years. Millions of people receive the vaccine, and its safety has been tested by time.

Each year, national drug regulatory authorities scrutinize a new vaccine before it is licensed. Countries also have systems in place to monitor and investigate all cases of adverse events following influenza immunization.

Quadrivalent vaccine – what is it?

The quadrivalent (quadrivalent) influenza vaccine is designed to protect against four different types of influenza viruses:

• two influenza A viruses;
• two influenza viruses type B.

In the past, influenza vaccines protected against three different influenza viruses (trivalent vaccines). These included influenza virus type A (h2N1) , influenza virus type A (h4N2) .

Contraindications

The main contraindication for influenza vaccination is an allergic reaction to the components of the vaccine and the general somatic condition (fever and other symptoms of SARS).

Before vaccination, the patient must be examined by a doctor.

When you get the flu shot

It is best to get vaccinated before flu season starts. Influenza vaccination campaigns usually take place from September 1 to November 1, before the start of the seasonal circulation of the virus (if necessary, immunization is extended).

However, it’s never too late to get a vaccine – getting vaccinated makes you more likely not to get sick and reduces your risk of serious consequences from the flu.

Why is it necessary to vaccinate every winter?

Group viruses are constantly mutating, and different strains can circulate every year. In addition, immunity from vaccination weakens over time. The composition of seasonal influenza vaccines is updated each year to provide the greatest protection against viruses circulating at that time.

Where to get a flu shot in Sevastopol

Adults should contact the clinic at the place of attachment or mobile vaccination stations. Children are vaccinated in kindergartens and schools.

There are vaccination points in Sevastopol (you can sign up for each of them regardless of attachment):

(according to the work schedule of polyclinics)

• Polyclinic No. 1 (Adm. Oktyabrsky St., 19)
• Polyclinic No. 2 (Eroshenko St., 11)
• Polyclinic No. 3 (B. Mikhailova st., 4)
• Polyclinic No. 4 (at Suprun, 19 and Silaeva st., 3)
• Polyclinic No. 5 (pl. Gennerich, 1, St. Budischeva, 9)
• Outpatient clinic for general practice and family medicine (Shevchenko str., 3)
• Polyclinic for the adult population (Levanevskogo str., 25)
• Polyclinic Inkerman (st. Umrikhin, 16)
• Polyclinic for adults (street Mira, 5)

Mobile vaccination stations

(7 days a week from 9:00 to 19:00)

Vaccination in mobile points is carried out on a first-come, first-served basis. You must have a passport, medical policy and SNILS with you.

Additional vaccination points

(according to the work schedules of feldsher-obstetric stations and rural outpatient clinics)

GBUZS “City Hospital No. 4”

• medical outpatient clinic in Kacha;

• medical outpatient clinic Verkhnesadovoe;

• medical ambulance station Solnechny;

• medical outpatient clinic Osipenko;

• feldsher-obstetric station with. Cherry;

• feldsher-obstetric station with. Andreevka;

• feldsher-obstetric station with. Far;

• feldsher-obstetric station with. rotary;

• feldsher-obstetric station with. Front.

GBUZS “Sevastopol City Hospital No. 9”

• medical outpatient clinic Eagle;

• medical outpatient clinic Ternovka;

• medical outpatient clinic p. Sugarloaf.

Sevastopol Tuberculosis Dispensary

• Fiolentovskoe Highway 17, +7(8692) 41-78-97

Sevastopol city oncological dispensary. A.A. Zadorozhny
• at st. Eroshenko, 13, (only for patients registered with a medical organization), +7(978) 254-50-08, +7(978) 254-50-63

A referral from a doctor is not required. To get vaccinated, it is enough to contact the reception of the clinic. No special preparatory procedures are required before vaccination.

FAQ

Can I be forced to get vaccinated (in kindergarten, at school, at work )?

No. Vaccination is voluntary.

Where do they get vaccinated?

Shoulder.

Can the vaccine be wetted?

Undesirable on the first day.

Can I get the flu and pneumococcal vaccine at the same time?

Yes, it is possible and even desirable.